In the Phase II SYNERGY-NASH trial, up to 62% of tirzepatide recipients achieved MASH resolution without worsening of fibrosis, versus 10% in the placebo group, while up to 55% saw improvement of at least one fibrosis stage without worsening of MASH, versus 30% of placebo recipients
So many people, when they stop it, if they havent changed their lifestyle, their eating habits, their eating behavior, all those things can return and then the weight can be regained. Dr
You are allergic to semaglutide or any of the ingredients in semaglutide
However, Rybelsus comes with strict dosing requirements that some people find inconvenient
Sublingual versions require a prescription and guidance on dosage, so be sure to discuss this option with a provider at Pure Med Spa to see if it suits your lifestyle